Table 2 Therapeutic indicator of cognition: ΔMMSE
Therapeutic response, N (%) | Favorablea,21 (31.7) | Poorb,39(68.3) | p-value |
|---|---|---|---|
Age, years (mean ± SD) | 82.3 ± 5.6 | 82.5 ± 5.6 | 0.908 |
Education, years (mean ± SD) | 7.5 ± 4.7 | 8.1 ± 4.8 | 0.634 |
Gender, female (%) | 15 (71.4) | 31 (79.5) | 0.482 |
1st CDR-SB | 7.4 ± 3.6 | 8.4 ± 3.3 | 0.292 |
1st MMSE | 14.1 ± 7.1 | 14.6 ± 5.9 | 0.766 |
Cilostazol use | 0.015 | ||
No | 6 (20.0) | 24 (80.0) | |
Yes | 15 (50.0) | 15 (50.0) | |
ApoE ε4(+),n (%) | 7 (35.0) | 5 (14.3) | 0.074 |